DRAXIS appoints new president
Richard Flanagan has been named president of DRAXIS’ radiopharmaceutical subsidiary, DRAXIMAGE. He has succeeded Ray Dore, who plans to retire in September but will continue to serve as a special advisor. Flanagan, who is currently executive vice
Richard Flanagan has been named president of DRAXIS’ radiopharmaceutical subsidiary, DRAXIMAGE. He has succeeded Ray Dore, who plans to retire in September but will continue to serve as a special advisor. Flanagan, who is currently executive vice president, has been with DRAXIMAGE since its founding in 1997.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Recent Videos
Related Content
